Results 101 to 110 of about 5,388,952 (345)
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
Frontiers in Aging Neuroscience, 2018 Background: Cerebrospinal fluid (CSF) biomarkers (Aβ peptides and tau proteins) improved the diagnosis of Alzheimer’s disease (AD) in research and clinical settings.Sylvain Lehmann, Sylvain Lehmann, Constance Delaby, Constance Delaby, Guilaine Boursier, Cindy Catteau, Nelly Ginestet, Laurent Tiers, Aleksandra Maceski, Sophie Navucet, Claire Paquet, Julien Dumurgier, Eugeen Vanmechelen, Hugo Vanderstichele, Audrey Gabelle, Audrey Gabelle, Audrey Gabelle +16 moredoaj +1 more sourceIntein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar +9 morewiley +1 more sourceSubmillimeter ALMA Observations of the Dense Gas in the Low-Luminosity
Type-1 Active Nucleus of NGC 1097
, 2013 We present the first 100 pc scale view of the dense molecular gas in the
central ~ 1.3 kpc region of the type-1 Seyfert NGC 1097 traced by HCN (J=4-3)
and HCO+ (J=4-3) lines afforded with ALMA band 7.Curran, Max T., Doi, Akihiro, Espada, Daniel, Fathi, Kambiz, Harada, Nanase, Hsieh, Pei-Ying, Imanishi, Masatoshi, Izumi, Takuma, Kohno, Kotaro, Krips, Melanie, Lundgren, Andreas A., Martín, Sergio, Matsushita, Satoki, Meier, David S., Nakai, Naomasa, Nakajima, Taku, Regan, Michael W., Schinnerer, Eva, Sheth, Kartik, Takano, Shuro, Tamura, Yoichi, Taniguchi, Akio, Terashima, Yuichi, Tosaki, Tomoka, Turner, Jean L., Wiklind, Tommy +25 morecore +1 more sourceImproving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann +15 morewiley +1 more sourceDark Energy Survey Year 3 results: Exploiting small-scale information with lensing shear ratios [PDF]
, 2022 C. Sánchez, J. Prat, Georgios Zacharegkas, Shivam Pandey, Eric J. Baxter, G. M. Bernstein, J. Blazek, R. Cawthon, C. Chang, E. Krause, Pablo Lemos, Y Park, Marco Raveri, Javier Sánchez, M. A. Troxel, A. Amon, Xiao Fang, O. Friedrich, D. Gruen, A. Porredon, L. F. Secco, S. Samuroff, A. Alarcon, O. Alves, F. Andrade-Oliveira, K. Bechtol, M. R. Becker, H. Camacho, A. Campos, A. Carnero Rosell, M. Carrasco Kind, R. Chen, A. Choi, M. Crocce, C. Davis, J. De Vicente, Joseph DeRose, Eleonora Di Valentino, H. T. Diehl, Scott Dodelson, C. Doux, A. Drlica-Wagner, K. Eckert, T. F. Eifler, F. Elsner, J. Elvin-Poole, S. Everett, A. Ferté, P. Fosalba, M. Gatti, G. Giannini, R. A. Gruendl, I. Harrison, W. G. Hartley, K. Herner, Eric Huff, Dragan Huterer, Mike Jarvis, Bhuvnesh Jain, N. Kuropatkin, P.-F. Léget, N. MacCrann, J. McCullough, J. Muir, J. Myles, A Navarro-Alsina, R. P. Rollins, A. Roodman, R. Rosenfeld, E. S. Rykoff, I. Sevilla-Noarbe, E. Sheldon, T. Shin, A. Troja, I. Tutusaus, T. N. Varga, Risa H. Wechsler, B. Yanny, B. Yin, Y Zhang, J. Zuntz, T. M. C. Abbott, M. Aguena, S. Allam, David Bacon, E. Bertin, S Bhargava, D. Brooks, E. Buckley‐Geer, D. L. Burke, J. Carretero, M. Costanzi, L. da Costa, M. E. S. Pereira, S. Desai, J. P. Dietrich, P. Doel, A. E. Evrard, I. Ferrero, B. Flaugher +99 moreopenalex +1 more sourceClass IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio +13 morewiley +1 more sourceScale-model tests of railway rolling noise
Mechanical Engineering Journal, 2019 The rolling noise generated by railway vehicles was evaluated in scale-model tests. The similarity relations associated with wheel/rail noise were derived and the full-scale phenomena were estimated from the scale-model tests. When converting scale-model Takeshi SUEKI, Toshiki KITAGAWA, Toru YAMAZAKI +2 moredoaj +1 more sourceThe power of Bayesian evidence in astronomy
, 2011 We discuss the use of the Bayesian evidence ratio, or Bayes factor, for model
selection in astronomy. We treat the evidence ratio as a statistic and
investigate its distribution over an ensemble of experiments, considering both
simple analytical examples Berger, C. R. Jenkins, Efstathiou, Feroz, Fisher, Gelman, Gregory, Heavens, Hobson, J. A. Peacock, Jaynes, Jeffreys, Liddle, Lindley, Mackay, Mukherjee, Niarchou, Sellke, Skilling, Susskind, Tegmark, Trotta, Trotta, Trotta, Zweig +24 morecore +1 more sourceIn vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations
Molecular Oncology, EarlyView.Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow +10 morewiley +1 more source